These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 37678309)

  • 1. Mpox in people with past infection or a complete vaccination course: a global case series.
    Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM;
    Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study.
    Bertran M; Andrews N; Davison C; Dugbazah B; Boateng J; Lunt R; Hardstaff J; Green M; Blomquist P; Turner C; Mohammed H; Cordery R; Mandal S; Campbell C; Ladhani SN; Ramsay M; Amirthalingam G; Bernal JL
    Lancet Infect Dis; 2023 Jul; 23(7):828-835. PubMed ID: 36924787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia.
    Gilbert M; Ablona A; Chang HJ; Grennan T; Irvine MA; Sarai Racey C; Salway T; Naus M; Dawar M; Ogilvie G
    Vaccine; 2023 Apr; 41(15):2485-2494. PubMed ID: 36894397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.
    Ladhani SN; Dowell AC; Jones S; Hicks B; Rowe C; Begum J; Wailblinger D; Wright J; Owens S; Pickering A; Shilltoe B; McMaster P; Whittaker E; Zuo J; Powell A; Amirthalingam G; Mandal S; Lopez-Bernal J; Ramsay ME; Kissane N; Bell M; Watson H; Ho D; Hallis B; Otter A; Moss P; Cohen J
    Lancet Infect Dis; 2023 Sep; 23(9):1042-1050. PubMed ID: 37336224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey-based assessment of rates and covariates of mpox diagnosis and vaccination provides evidence to refine eligibility criteria for mpox vaccination among gay, bisexual and other men who have sex with men in the Netherlands.
    Adam PCG; Op de Coul ELM; Zantkuijl P; Xiridou M; Bos H; Blom C; Ketsuwan I; Te Wierik MJM; David S; de Wit JBF
    Front Public Health; 2024; 12():1194844. PubMed ID: 38351958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
    Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mpox outbreak 2022: an overview of all cases reported to the Cologne Health Department.
    Kröger ST; Lehmann MC; Treutlein M; Fiethe A; Kossow A; Küfer-Weiß A; Nießen J; Grüne B
    Infection; 2023 Oct; 51(5):1369-1381. PubMed ID: 36787016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling study.
    Zhang XS; Mandal S; Mohammed H; Turner C; Florence I; Walker J; Niyomsri S; Amirthalingam G; Ramsay M; Charlett A; Vickerman P
    Lancet Infect Dis; 2024 Jan; 24(1):65-74. PubMed ID: 37708908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mpox Outbreak - Los Angeles County, California, May 4-August 17, 2023.
    Leonard CM; Poortinga K; Nguyen E; Karan A; Kulkarni S; Cohen R; Garrigues JM; Marutani AN; Green NM; Kim AA; Sey K; Pérez MJ
    MMWR Morb Mortal Wkly Rep; 2024 Jan; 73(2):44-48. PubMed ID: 38236779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
    Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of mpox infection in individuals who received a first dose of modified vaccinia Ankara immunisation.
    Agunbiade S; Burton F; Muirhead J; Whitlock GG; Girometti N
    Sex Transm Infect; 2023 May; 99(3):198-199. PubMed ID: 36596674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics.
    Candela C; Raccagni AR; Bruzzesi E; Bertoni C; Rizzo A; Gagliardi G; Canetti D; Gianotti N; Mileto D; Gismondo MR; Castagna A; Nozza S;
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mpox in a Couple Living with HIV: Relapse or Reinfection?
    Rocha SQ; Fonsi M; Tancredi MV; Alencar HDR; Abbud A; da Silva MH
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):610-615. PubMed ID: 37140474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration.
    Lucero-Obusan C; Oda G; Schirmer P; Edson C; Trevino C; Elbeik T; Holodniy M
    J Infect Dis; 2024 Mar; 229(Supplement_2):S172-S180. PubMed ID: 38134309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
    Payne AB; Ray LC; Cole MM; Canning M; Houck K; Shah HJ; Farrar JL; Lewis NM; Fothergill A; White EB; Feldstein LR; Roper LE; Lee F; Kriss JL; Sims E; Spicknall IH; Nakazawa Y; Gundlapalli AV; Shimabukuro T; Cohen AL; Honein MA; Mermin J; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1560-1564. PubMed ID: 36480479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
    Deputy NP; Deckert J; Chard AN; Sandberg N; Moulia DL; Barkley E; Dalton AF; Sweet C; Cohn AC; Little DR; Cohen AL; Sandmann D; Payne DC; Gerhart JL; Feldstein LR
    N Engl J Med; 2023 Jun; 388(26):2434-2443. PubMed ID: 37199451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
    Aden D; Zaheer S; Kumar R; Ranga S
    J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study.
    Angelo KM; Smith T; Camprubí-Ferrer D; Balerdi-Sarasola L; Díaz Menéndez M; Servera-Negre G; Barkati S; Duvignaud A; Huber KLB; Chakravarti A; Bottieau E; Greenaway C; Grobusch MP; Mendes Pedro D; Asgeirsson H; Popescu CP; Martin C; Licitra C; de Frey A; Schwartz E; Beadsworth M; Lloveras S; Larsen CS; Guagliardo SAJ; Whitehill F; Huits R; Hamer DH; Kozarsky P; Libman M;
    Lancet Infect Dis; 2023 Feb; 23(2):196-206. PubMed ID: 36216018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.